Trials / Completed
CompletedNCT01272882
Electrical Impedance Tomography (EIT) Monitoring in Adults With ALI or ARDS
Electrical Impedance Tomography (EIT) Monitoring: A Pilot Comparison to Standard of Care Assessments in Adults With Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Christiana Care Health Services · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Electrical impedance tomography (EIT) monitoring has been researched as a method to determine the spatial impedance distribution in a body cross section, but has yet to become an established clinical tool. EIT monitoring gives a dynamic, breath-to-breath measurement of both global and regional ventilation. Recently, there has been evidence that EIT monitoring has great potential to become a non-invasive bedside tool for assessment of regional lung ventilation without documented hazards. Potential applications include any adult patients in acute respiratory failure. Data collected from this research may contribute to improved patient safety outcomes. PURPOSE: The purpose of this pilot study is to examine the feasibility of using the EIT monitor in intensive care unit (ICU) setting on patients with acute respiratory failure and to compare the EIT monitor data to standard of care patient assessments. It is hypothesized that the EIT monitor, when applied to adults in acute respiratory failure, will correlate with conventional standard of care assessments for these patients.
Detailed description
INTRODUCTION: Electrical impedance tomography (EIT) monitoring has been researched as a method to determine the spatial impedance distribution in a body cross section, but has yet to become an established clinical tool. EIT monitoring gives a dynamic, breath-to-breath measurement of both global and regional ventilation. Recently, there has been evidence that EIT monitoring has great potential to become a non-invasive bedside tool for assessment of regional lung ventilation without documented hazards. Potential applications include any adult patients in acute respiratory failure. Data collected from this research may contribute to improved patient safety outcomes. PURPOSE: The purpose of this pilot study is to examine the feasibility of using the EIT monitor in ICU setting on patients with acute respiratory failure and to compare the EIT monitor data to standard of care patient assessments. It is hypothesized that the EIT monitor, when applied to adults in acute respiratory failure, will correlate with conventional standard of care assessments for these patients. METHOD: This pilot study design will consist of a prospective, blinded evaluation of the EIT monitor for patients with acute lung injury or acute respiratory distress syndrome. Once a patient has met the inclusion criteria and has signed informed consent: 1. EIT electrode chest band will be applied by trained respiratory care staff. Application includes elastic chest band with 16 electrodes. 2. EIT electrode chest band is connected to the EIT monitor which will be turned on and will monitor and store EIT data. 3. EIT monitoring will take place for 4 to 6 hours, during day shift (7am to 4pm) 4. Patient's may be monitored on three separate days. No interventions, tests or modifications to the standard of care will occur to patients for this pilot study of EIT monitoring. Clinicians guiding the care of these patients will be blinded to the EIT data. The EIT chest band will be removed if transport of the patient is necessary or if care is needed in the area of the chest band.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Electrical Impedance Tomography monitoring | Chest belt with 16 electrodes connected to the EIT device |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2011-01-10
- Last updated
- 2017-05-25
- Results posted
- 2013-01-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01272882. Inclusion in this directory is not an endorsement.